Loading…
CIK 0001910456 • 7 13F filings • May 15, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("lynx1-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ADC THERAPEUTICS SA | SHS | $5.3M | 1.1% | 1,325,848 SH | New |
| ALLOGENE THERAPEUTICS INC | COM | $677K | 0.1% | 546,119 SH | New |
| C4 THERAPEUTICS INC | COM STK | $15.8M | 3.2%Prev: 4.0% | 7,098,133 SH | Decreased-228,558 SH |
| CULLINAN THERAPEUTICS INC | COM | $34.2M | 7.0%Prev: 18.9% | 5,766,090 SH | Decreased-3,197,410 SH |
| DENALI THERAPEUTICS INC | COM | $3.8M | 0.8%Prev: 0.0% | 261,687 SH | Increased+250,029 SH |
| DESIGN THERAPEUTICS INC | COM | $497K | 0.1% | 65,954 SH | New |
| GH RESEARCH PLC | ORDINARY SHARES | $104.3M | 21.2%Prev: 41.2% | 8,601,189 SH | Decreased-4,662,099 SH |
| IBIO INC | COM NEW | $874K | 0.2% | 1,055,897 SH | New |
| MERUS N V | COM | $144.4M | 29.4% | 1,534,141 SH | New |
| PASSAGE BIO INC | COM NEW | $5.0M | 1.0%Prev: 0.4% | 623,704 SH | Increased-50,055 SH |
| PRECISION BIOSCIENCES INC | COM NEW | $5.8M | 1.2%Prev: 0.9% | 1,042,596 SH | Decreased+92,130 SH |
| PROTAGONIST THERAPEUTICS INC | COM | $46.5M | 9.5% | 700,014 SH | New |
| STOKE THERAPEUTICS INC | COM | $109.9M | 22.4%Prev: 15.3% | 5,404,674 SH | Decreased+1,366,270 SH |
| TSCAN THERAPEUTICS INC | COM | $14.3M | 2.9%Prev: 0.9% | 7,857,347 SH | Increased-161,801 SH |
| 13F-HR/A |
| 0001910456-26-000004 |
| $865.5M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001085146-25-005127 | $346.2M | View |
| May 4, 2026 | Q1 2026 | 13F-HR | 0001910456-26-000002 | $632.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001892688-25-000120 | $279.2M | View |